ClinConnect ClinConnect Logo
Search / Trial NCT06186245

Starvation in the Treatment of Diabetic Ketoacidosis

Launched by TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER · Dec 15, 2023

Trial Information

Current as of June 26, 2025

Enrolling by invitation

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Males and females with the diagnosis of diabetic ketoacidosis (defined as blood glucose greater than 250 mg/dL, arterial pH less than 7.3, serum bicarbonate less than 15 mEq/L, and the presence of ketonemia or ketonuria)
  • Age between 18-89
  • Admission to the Medical Intensive Care Unit
  • Able to provide informed consent
  • Exclusion Criteria:
  • Pregnant and breast-feeding women
  • Institutionalized patients or prisoners
  • Patients unable to eat by mouth, including intubation, presence of any tube used for enteral feeding (nasogastric tube, orogastric tube, PEG tube, etc.), medical conditions requiring parenteral feeding, and a history of a medical condition that prevented oral intake prior to admission, including achalasia, esophageal cancer, stroke with residual deficits preventing oral intake, amyotrophic lateral sclerosis, or head and neck trauma.

About Texas Tech University Health Sciences Center

Texas Tech University Health Sciences Center (TTUHSC) is a prominent academic institution dedicated to improving health outcomes through innovative research, education, and clinical practice. As a leading sponsor of clinical trials, TTUHSC leverages its interdisciplinary expertise to advance medical knowledge and patient care. The institution is committed to conducting rigorous, ethically sound research that adheres to the highest standards of scientific integrity. With a focus on diverse health issues, TTUHSC fosters collaboration among healthcare professionals, researchers, and community stakeholders to translate research findings into effective treatments and interventions for the benefit of the populations it serves.

Locations

Lubbock, Texas, United States

Patients applied

0 patients applied

Trial Officials

Kenneth Kenneth, MD

Principal Investigator

Texas Tech University Health Science Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported